Halozyme Therapeutics shares owned by Lindenwold Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lindenwold Advisors
from 13F filings
Historical chart of Lindenwold Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lindenwold Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Lindenwold Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $417k | 8.0k | 52.02 |
| 2025-03-31 | $509k | 8.0k | 63.81 |
| 2024-12-31 | $239k | 5.0k | 47.81 |